Skip to main content
Premium Trial:

Request an Annual Quote

Roy Smythe

Roy Smythe has been appointed as CEO of SomaLogic. He will replace Alister Reynolds, who became CEO in early 2017 and who will remain on the company's board. Smythe joins the Boulder, Colorado-based firm from Royal Philips, where he was chief medical officer for strategy and partnerships. Prior to that, he was CMO at Valence Health, and before that, CMO of healthcare technology accelerator AVIA. Previously, he was chair of the Department of Surgery at Baylor Scott & White Health and the Texas A&M Health Science Center College of Medicine, where he was also medical director of innovation.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.